Privileged Structures and Analogue-Based Drug Discovery

Analogue-based Drug Discovery

Volumn , Issue , 2006, Pages 53-68

  Kubinyi, Hugo ^a  

^a NONE

Author keywords

Agonists and antagonists; Analogue based drug discovery; Drug action on target classes; GPCR ligands; Integrin ligands; Kinase inhibitors; Neurotransmitter uptake inhibitors; Nuclear receptor ligands; Phosphodiesterase inhibitors; Privileged structures; Side effects

Indexed keywords

EID: 36749073295     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527608001.ch3     Document Type: Chapter

References (45)

1. Frantz S. Nature Rev. Drug Discov., 2004, 3, 103-104.
2. Frantz S, Smith A. Nature Rev. Drug Discov., 2003, 2, 95-96.
3. Caron PR, Mullican MD, Mashal RD, Wilson KP, Su MS, Murcko MA. Curr. Opin. Chem. Biol., 2001, 5, 464-470.
4. Bleicher KH. Curr. Med. Chem., 2002, 9, 2077-2084.
5. Jacoby E, Schuffenhauer A, Floersheim P. Drug News Perspect., 2003, 16, 93-102.
6. Kubinyi H, Müller G (Eds.). Chemogenomics in Drug Discovery - A Medicinal Chemistry Perspective. Vol. 22. Methods and Principles in Medicinal Chemistry. Mannhold R, Kubinyi H, Folkers G (Eds.). Wiley-VCH, Weinheim, 2004.
7. Evans BS, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, Hirshfield J. J. Med. Chem., 1988, 31, 2235-2246.
8. Patchett AA, Nargund RP. Annu. Rep. Med. Chem., 2000, 35, 289-298.
9. Fischer E. Ber. Dtsch. Chem. Ges., 1894, 27, 2985-2993.
10. Müller G. Drug Discovery Today, 2003, 8, 681-691.
11. Müller G. In: Kubinyi H, Müller G (Eds.). Chemogenomics in Drug Discovery - A Medicinal Chemistry Perspective. Vol. 22. Methods and Principles in Medicinal Chemistry. Mannhold R, Kubinyi H, Folkers G (Eds.). Wiley-VCH, Weinheim, 2004, pp. 7-41.
12. Burger A. A Guide to the Chemical Basis of Drug Design. John Wiley & Sons, New York, 1983.
13. de Stevens G. Prog. Drug Res., 1986, 30, 189-203.
14. Roberts RM. Serendipity. Accidental Discoveries in Science. John Wiley & Sons, New York, 1989.
15. Sneader W. Drug Prototypes and their Exploitation. John Wiley & Sons, Chichester, 1996.
16. Kubinyi H. J. Receptor Signal Transduct. Res., 1999, 19, 15-39.
17. Kubinyi H. In: Kubinyi H, Müller G (Eds.). Chemogenomics in Drug Discovery - A Medicinal Chemistry Perspective. Vol. 22. Methods and Principles in Medicinal Chemistry. Mannhold R, Kubinyi H, Folkers G (Eds.). Wiley-VCH, Weinheim, 2004, pp. 43-67.
18. Wermuth CG. Med. Chem. Res., 2001, 10, 431-439.
19. Wermuth CG. J. Med. Chem., 2004, 47, 1303-1314.
20. Underwood DJ, Strader CD, Rivero R, Patchett AA, Greenlee W, Prendergast K. Chem. Biol., 1994, 1, 211-221.
21. Perlman S, Costa-Neto CM, Miyakawa AA, Schambye HT, Hjorth SA, Paiva ACM, Rivero RA, Greenlee WJ, Schwartz TW. Mol. Pharmacol., 1997, 51, 301-311.
22. Beeley NRA. Drug Discovery Today, 2000, 5, 354-363.
23. Ooms F. Curr. Med. Chem., 2000, 7, 141-158.
24. Dukat M, El-Zahabi M, Ferretti G, Damaj MI, Martin BR, Young R, Glennon RA. Bioorg. Med. Chem. Lett., 2002, 12, 3005-3007.
25. Römer D, Büscher HH, Hill RC, Maurer R, Petcher TJ, Zeugner H, Benson W, Finner E, MilkowskiW, Thies PW. Nature, 1982, 298, 759-760.
26. Chang RSL, Lotti VJ, Chen TB, Keegan ME. Neurosci. Lett., 1982, 72, 211-214.
27. Pernerstorfer J. In: Handbook of Combinatorial Chemistry. Drugs, Catalysts, Materials, Volume II. Nicolaou KC, Hanko R, Hartwig W (Eds.). Wiley-VCH, Weinheim, 2002, pp. 725-742.
28. Schaus JM, Bymaster FP. Annu. Rep. Med. Chem., 1998, 33, 1-10.
29. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT. Neuropsychopharmacology, 1996, 14, 87-96.
30. Bymaster FP, Nelson DL, DeLapp NW, Falcone JF, Eckols K, Truex LL, Foreman MM, Lucaites VL, Calligaro DO. Schizophr. Res., 1999, 37, 107-122.
31. Ursini A, Capelli AM, Carr RA, Cassara P, Corsi M, Curcuruto O, Curotto G, Dal Cin M, Davalli S, Donati D, Feriani A, Finch H, Finizia G, Gaviraghi G, Marien M, Pentassuglia G, Polinelli S, Ratti E, Reggiani AM, Tarzia G, Tedesco G, Tranquillini ME, Trist DG, Van Amsterdam FT, Reggiani A. J. Med. Chem., 2000, 43, 3596-3613; erratum in J. Med. Chem., 2000, 43, 5057.
32. Lopez-Rodriguez ML, Morcillo MJ, Benhamu B, Rosado ML. J. Comput.- Aided Mol. Design, 1997, 11, 589-599.
33. Samanen JM, Ali FE, Barton LS, Bondinell WE, Burgess JL, Callahan JF, Calvo RR, Chen W, Chen L, Erhard K, Feuerstein G, Heys R, Hwang SM, Jakas DR, Keenan RM, Ku TW, Kwon C, Lee C-P, Miller WH, Newlander KA, Nichols A, Parker M, Peishoff CE, Rhodes G, Ross S, Shu A, Simpson R, Takata D, Yellin TO, Uzsinskas I, Venslavsky JW, Yuan CK, Huffman WF. J. Med. Chem., 1996, 39, 4867-4870.
34. Keenan RM, Miller WH, Kwon C, Ali FE, Callahan JF, Calvo RR, Hwang SM, Kopple KD, Peishoff CE, Samanen JM, Wong AS, Yuan CK, Huffman WF. J. Med. Chem., 1997, 40, 2289-2292.
35. Klebl BM, Daub H, Keri G. In: Kubinyi H, Müller G (Eds.). Chemogenomics in Drug Discovery - A Medicinal Chemistry Perspective. Vol. 22. Methods and Principles in Medicinal Chemistry. Mannhold R, Kubinyi H, Folkers G (Eds.). Wiley-VCH, Weinheim, 2004, pp. 167-190.
36. Buijsman R. In: Kubinyi H, Müller G (Eds.). Chemogenomics in Drug Discovery - A Medicinal Chemistry Perspective. Vol. 22. Methods and Principles in Medicinal Chemistry. Mannhold R, Kubinyi H, Folkers G (Eds.). Wiley-VCH, Weinheim, 2004, pp. 191-219.
37. Capdeville R, Buchdunger E, Zimmermann J, Matter A. Nature Rev. Drug Discov., 2002, 1, 493-502.
38. Hendrix M. Kallus C. In: In: Kubinyi H, Müller G (Eds.). Chemogenomics in Drug Discovery - A Medicinal Chemistry Perspective. Vol. 22. Methods and Principles in Medicinal Chemistry. Mannhold R, Kubinyi H, Folkers G (Eds.). Wiley- VCH, Weinheim, 2004, pp. 243-288.
39. Stamford AW. Annu. Rep. Med. Chem., 2002, 37, 53-64.
40. Broughton BJ, Chaplen P, Knowles P, Lunt E, Marshall SM, Pain DL, Wooldridge KRH. J. Med. Chem., 1975, 18, 1117-1122.
41. Fujita T. In: Quantitative Drug Design. Ramsden CA (Ed.). Vol. 4 of Comprehensive Medicinal Chemistry. The Rational Design, Mechanistic Study & Therapeutic Application of Chemical Compounds. Hansch C, Sammes PG, Taylor JB (Eds.). Pergamon Press, Oxford, 1990, pp. 497-560.
42. Wooldridge KRH. Personal communication, 1976.
43. Kling J. Modern Drug Discovery, November/December 1998, pp. 31-38.
44. Gundertofte K, Bogeso KP, Liljefors T. In: Computer-Assisted Lead Finding and Optimization. Proceedings, 11th European Symposium on Quantitative Structure-Activity Relationships, Lausanne, 1996. van de Waterbeemd H, Testa B, Folkers G (Eds.). Verlag Helvetica Chimica Acta and VCH, Basel, Weinheim, 1997; pp. 445-459.
45. Anonymous. Nature Rev. Drug Discov., 2004, 3, 101.